Search for content, post, videos

FDA expands Dignicap clearance in the US

johan-ericsson-dignitana
Dignitana has received clearance from the U.S. Food and Drug Administration (FDA) to expand use of its medical device to patients in the United States receiving chemotherapy for solid tumor cancers. Originally cleared in December 2015 by the FDA as the first scalp cooling device for use in wome
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.